Template:Neonatal HSV antivirals: Difference between revisions
(Created page with "===Disseminated or CNS Neonatal HSV=== *Acyclovir 20 mg/kg/dose Q8 IV x 21 days *Add Trifluridine ophthalmic solution Q2 hours for ocular involvement *Always refer to Opht...") |
(minor edits to the initial - added meds for SBI eval (i.e. febrile neonate) - broadened options for ocular coverage) |
||
| Line 1: | Line 1: | ||
===Disseminated or CNS [[Neonatal HSV]]=== | ===Disseminated or CNS [[Neonatal HSV]]=== | ||
*Acyclovir 20 mg/kg | *Acyclovir 20 mg/kg IV every 8 hours | ||
* | *If ocular involvement: | ||
* | **1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine | ||
**Optho consult | |||
*As for any febrile neonate SBI evaluation: | |||
**Ampicillin + gentamycin | |||
***May substitute gentamycin with cefotaxime/ceftazidime | |||
Revision as of 21:22, 2 July 2016
Disseminated or CNS Neonatal HSV
- Acyclovir 20 mg/kg IV every 8 hours
- If ocular involvement:
- 1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
- Optho consult
- As for any febrile neonate SBI evaluation:
- Ampicillin + gentamycin
- May substitute gentamycin with cefotaxime/ceftazidime
- Ampicillin + gentamycin